Medtech fundings pass $400 million for March 2012

Financings and investment in medical technology companies for March 2012 blew by the $400 million mark with a $65 million Series C funding by aesthetics and plastic surgery device maker, Sientra, Inc.  Total financings for the month reached $450 million.  Top fundings for the month include:

  • Sientra, Inc. — $65 million
  • ViewRay, Inc. — $45 million
  • Aastrom Biosciences, Inc. — $40 million
  • Myoscience, Inc. — $33 million
  • Relievant Medsystems, Inc. — $30 million

For a complete list of medtech financings for March 2012, see link.

Published by

P. Driscoll

Patrick Driscoll founded MedMarket Diligence and has become a leading source of analysis and insight in medical technology markets. He previously co-founded Medtech Insight and was a principal at Medical Data International. He has 25 years of experience assessing current and potential markets for medical technologies.

Leave a Reply